These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
    Author: Dahl E, Offer-Ohlsen D, Lillevold PE, Sandvik L.
    Journal: Clin Pharmacol Ther; 1984 Jul; 36(1):116-20. PubMed ID: 6734040.
    Abstract:
    The efficacy of transdermal scopolamine, oral meclizine, and placebo in protection against motion sickness was compared in a double-blind crossover study. Thirty-six healthy subjects were exposed to motion three times for 90 min in a ship-motion simulator. Transdermal applications were made and tablets were taken at least 12 and 2 hr before exposure to motion. Transdermal scopolamine provided better protection than placebo or meclizine. Dryness of mouth was the only side effect reported more frequently for one regimen, transdermal scopolamine.
    [Abstract] [Full Text] [Related] [New Search]